1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Seed Grant Program (Sue & Bill Gross Stem Cell Research Center) is sponsored by Sue & Bill Gross Stem Cell Research Center (UC Irvine). The Seed Grant Program provides modest grants to researchers at the early stages of their work, enabling scientists with innovative ideas to initiate bold research in stem cell biology and regenerative medicine.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
FDA Approves CIRM-Funded Gene Therapy Pioneered by UCLA's Don Kohn, MD Watch Don Kohn's SCRC community lecture First Patient Treated in Huntington's Disease Neural Stem Cell Trial Today’s UC Irvine Stem Cell Research Center is a dynamic center encompassing a diverse array of interdisciplinary investigators that span the schools of Medicine, Biological Sciences, Pharmacy and Pharmaceutical Sciences, Engineering, Arts, and the Program in Public Health.
Our state-of-the-art, LEED Platinum certified research and clinical building houses 25 of our 65 center faculty members. Center faculty have obtained more than $275 million dollars in grant and foundation funds, including over $165 million dollars from the California Institute for Regenerative Medicine.
Our research programs include two National Institutes of Health (NIH)-sponsored T32 training grants, NIH R25 training program, 2 CIRM training grants supporting trainees from undergraduate through to postdoctoral and clinical fellows, a NIAMS P30 skin biology research center grant, state-of-the-art shared equipment and research services cores, community lecture series, an annual stem cell science symposium, and numerous seminar series.
Research areas, available resources and clinical trials Learn about our clinical research and trials Learn how you can support stem cell research at UCI See the latest news, videos and upcoming events UCI Health Tests Promising Cell Therapy for Lupus UCI Health opens clinical testing FT819, an investigational CAR T-cell therapy for lupus patients.
The treatment shows promise for long-term remission, with a California participant experiencing significant symptom improvement. Dr. Sheetal Desai leads the Alpha Clinic trial site.
CIRM Award Funds UC Irvine Huntington Disease Research Congratulations to Leslie Thompson on receiving a nearly $12 million grant from the California Institute for Regenerative Medicine to conduct the first-in-humans clinical trial of neural stem cell therapy for Huntington’s disease, beginning in mid-2026.
Groundbreaking Huntington's Disease Stem Cell Trial Begins at UCI Health Leslie Thompson is spearheading the world's first neural stem cell trial for Huntington's disease, marking a historic milestone for UCI Health. The study offers renewed hope to patients facing a devastating and incurable disease. Community lectures, special events and opportunities to engage.
Find details for future events here. When Skin Fails to Heal: Molecular Control of Human Skin Repair Marjana Tomic-Canic, Ph. D.
- Professor, University of Miami Gross Hall, Thorp Conference Center 4001 & Hybrid Event May 22, 2026 | 11:00 AM—12:00 PM Pacific Time Zoom Link: https://uci. zoom.
us/j/96362697873 Meeting ID: 963 6269 7873 Changing Paradigms in the Treatment of Acute Lymphoblastic Leukemia in Adults Alex Minella, MD & Nick Pannunzio, PhD Gross Hall, Thorp Conference Center 4001 June 9, 2026 | 7:00-8:00 PM Pacific Time iPSC-derived Immune Cells for Immunotherapy Jianhua Yu, Ph. D.
- UC Irvine Gross Hall, Thorp Conference Center 4001 June 12, 2026 | 11:00 AM—12:00 PM Pacific Time Cutting Edge Psoriasis: Updates on Pathogenesis and Management Presenter: "Wilson Liao, M. D. - Professor, University of California, San Francisco" Gross Hall, Thorp Conference Center June 26, 2026 | 1:00 - 2:00 PM Pacific Time Zoom Link: https://uci.
zoom. us/j/96362697873 Meeting ID: 963 6269 7873 At the University of California, Irvine, providing a culture of inclusion and equal opportunity for people with disabilities is a campuswide responsibility and commitment. If you have difficulty accessing any materials on this site, please email us at SCRCdirector@hs.
uci. edu.
According to the current listing, eligibility includes: Top stem cell investigators from across the UCI campus are eligible. Only unfunded research projects are considered. Confirm the full requirements in the official notice before applying.
The current listing shows $25,000 - $35,000 (past awards). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Seed Grant Program (Sue & Bill Gross Stem Cell Research Center) is funded by Sue & Bill Gross Stem Cell Research Center (UC Irvine). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Institute of Education Sciences has opened its first research competitions since early 2025: five FY27 competitions due October 1, 2026, with roughly $250 million planned across three tranches. But $224 million in withheld FY2025 funds may expire September 30, and topics are now fixed through FY2029.
Read articleUSDA-NIFA-WAMS-011117 posted September 4, 2026 with $1,905,210 across an estimated 12 awards of $25,000 to $200,000, closing September 14, 2026. The opportunity title is now simply "Science, Technology, Engineering, and Mathematics Fields." Assistance listing 10.318 still reads "Women and Minorities in Science, Technology, Engineering, and Mathematics Fields" — and NIFA's own program page says the program is not funded for FY2026.
Read articleAn Office of Legal Counsel opinion issued August 12, 2026 found LSAMP, AGEP, and the Hispanic-Serving Institution track of IUSE unconstitutional in their entirety, ordered five more programs run without race or sex preferences, and held that the congressional suballocations behind them are themselves unconstitutional — freeing the money as residual funds. Here is what it means for institutions holding those awards.
Read article